Enzo Biochem Stock Price Prediction
| ENZ Stock | USD 1.08 0.05 4.85% |
Oversold Vs Overbought
51
Oversold | Overbought |
Wall Street Target Price 5.5 | Quarterly Revenue Growth 0.072 |
Using Enzo Biochem hype-based prediction, you can estimate the value of Enzo Biochem from the perspective of Enzo Biochem response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Enzo Biochem to buy its stock at a price that has no basis in reality. In that case, they are not buying Enzo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Enzo Biochem after-hype prediction price | USD 1.08 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Enzo |
Enzo Biochem After-Hype Price Prediction Density Analysis
As far as predicting the price of Enzo Biochem at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Enzo Biochem or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Enzo Biochem, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Enzo Biochem Estimiated After-Hype Price Volatility
In the context of predicting Enzo Biochem's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Enzo Biochem's historical news coverage. Enzo Biochem's after-hype downside and upside margins for the prediction period are 0.05 and 2.92, respectively. We have considered Enzo Biochem's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Enzo Biochem is relatively risky at this time. Analysis and calculation of next after-hype price of Enzo Biochem is based on 3 months time horizon.
Enzo Biochem Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Enzo Biochem is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Enzo Biochem backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Enzo Biochem, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.09 | 1.84 | 0.00 | 0.00 | 6 Events / Month | 8 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.08 | 1.08 | 0.00 |
|
Enzo Biochem Hype Timeline
On the 30th of November Enzo Biochem is traded for 1.08. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Enzo is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at 0.09%. %. The volatility of related hype on Enzo Biochem is about 5436.36%, with the expected price after the next announcement by competition of 1.08. About 22.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.96. Some equities with similar Price to Book (P/B) outperform the market in the long run. Enzo Biochem recorded a loss per share of 0.19. The entity last dividend was issued on the 15th of November 2024. The firm had 105:100 split on the 21st of October 2004. Considering the 90-day investment horizon the next estimated press release will be in about 6 days. Check out Enzo Biochem Basic Forecasting Models to cross-verify your projections.Enzo Biochem Related Hype Analysis
Having access to credible news sources related to Enzo Biochem's direct competition is more important than ever and may enhance your ability to predict Enzo Biochem's future price movements. Getting to know how Enzo Biochem's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Enzo Biochem may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| FONR | Fonar | (0.14) | 6 per month | 0.00 | (0.08) | 2.15 | (2.97) | 10.84 | |
| BNR | Burning Rock Biotech | 0.35 | 3 per month | 7.80 | 0.05 | 16.01 | (7.67) | 46.14 | |
| SERA | Sera Prognostics | 1.07 | 9 per month | 4.58 | (0) | 9.55 | (7.60) | 27.67 | |
| OLK | Olink Holding AB | 0.01 | 10 per month | 0.48 | 0.04 | 1.58 | (1.37) | 4.37 | |
| LMDX | LumiraDx | 0.06 | 1 per month | 0.00 | (0.14) | 11.54 | (10.71) | 34.05 | |
| GTH | Genetron Holdings | (0.02) | 1 per month | 2.49 | (0.04) | 3.45 | (4.08) | 14.43 | |
| PMD | Psychemedics | 0.01 | 7 per month | 0.53 | (0.19) | 0.87 | (0.87) | 3.46 | |
| DRIO | DarioHealth Corp | (0.02) | 10 per month | 4.60 | (0.01) | 9.72 | (7.00) | 27.55 | |
| CSTL | Castle Biosciences | (0.87) | 11 per month | 2.71 | (0.0006) | 4.85 | (4.38) | 19.49 | |
| XGN | Exagen Inc | (0.07) | 8 per month | 3.40 | 0.09 | 9.62 | (6.46) | 25.65 | |
| BDSX | Biodesix | 0.01 | 8 per month | 0.00 | (0.1) | 5.95 | (5.61) | 29.48 | |
| STIM | Neuronetics | (0.08) | 7 per month | 7.44 | 0.05 | 8.99 | (9.24) | 59.07 | |
| SHC | Sotera Health Co | 0.13 | 8 per month | 0.00 | (0.13) | 3.74 | (3.99) | 13.40 |
Enzo Biochem Additional Predictive Modules
Most predictive techniques to examine Enzo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Enzo using various technical indicators. When you analyze Enzo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Enzo Biochem Predictive Indicators
The successful prediction of Enzo Biochem stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Enzo Biochem, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Enzo Biochem based on analysis of Enzo Biochem hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Enzo Biochem's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Enzo Biochem's related companies. | 2023 | 2024 (projected) | Dividend Yield | 2.31E-4 | 2.06E-4 | Price To Sales Ratio | 1.82 | 1.73 |
Story Coverage note for Enzo Biochem
The number of cover stories for Enzo Biochem depends on current market conditions and Enzo Biochem's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Enzo Biochem is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Enzo Biochem's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Enzo Biochem Short Properties
Enzo Biochem's future price predictability will typically decrease when Enzo Biochem's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Enzo Biochem often depends not only on the future outlook of the potential Enzo Biochem's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Enzo Biochem's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 50.9 M | |
| Cash And Short Term Investments | 52.4 M |
Additional Tools for Enzo Stock Analysis
When running Enzo Biochem's price analysis, check to measure Enzo Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzo Biochem is operating at the current time. Most of Enzo Biochem's value examination focuses on studying past and present price action to predict the probability of Enzo Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzo Biochem's price. Additionally, you may evaluate how the addition of Enzo Biochem to your portfolios can decrease your overall portfolio volatility.